Skip to main content
High RiskFDAfda-F-0098-2025UNDECLARED ALLERGEN

Hammond's Dark Chocolate Filled Mini Waffle Cones, packaged in a 4 oz (113g) Stand-Up Resealable Pouch. Item Number: FC23212; UPC 6 91355...

Category
Units Affected
29,844
Recall Date
August 30, 2024
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0098-2025.

Undeclared allergen: milk

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0098-2025.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Hammond's Candies Since 1920 Ii, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0098-2025.

Hammond's Candies Since 1920 II, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Hammond's Candies Since 1920 Ii, Llc Recall FAQ

Hammond's Candies Since 1920 Ii, Llc is the subject of a dairy safety report: Hammond's Dark Chocolate Filled Mini Waffle Cones, packaged in a 4 oz (113g) Stand-Up Resealable Pouch. Item Number: FC23212; UPC 6 91355.... The notice was published on August 30, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 29,844 units are potentially affected.